Predictors of responses to immune checkpoint blockade in advanced melanomaNicolas Jacquelot, Laurence Zitvogel, Moshe Sade-Feldman et al.|Nature Communications|2017Cited by 201
Sequential JAK inhibition enhances antitumor immunity after combined anti–PD-1 and anti-CTLA4Marcel Arias-Badia, Lawrence Fong, Peixi Chen et al.|JCI Insight|2025Cited by 4
674 Multi-omic single-cell assessment of castration-resistant prostate cancer patients receiving ¹ <sup>7</sup> <sup>7</sup> Lu-PSMA-617 and pembrolizumab shows timing of radioligand therapy alters immune responseAnusha Muralidhar, Lawrence Fong, Karen Law et al.|Regular and Young Investigator Award Abstracts|2025Cited by 0
Abstract 3980: Non-canonical CAR T cell states correlate with durable therapeutic responses in multiple myeloma patientsKai Wu, Lawrence Fong, Karen Law et al.|Cancer Research|2026Cited by 0
Abstract 2558: Multi-omic single-cell assessment of castration-resistant prostate cancer patients receiving177Lu-PSMA-617 and pembrolizumab shows timing of radioligand therapy alters immune responseAnusha Muralidhar, Lawrence Fong, Karen Law et al.|Cancer Research|2026Cited by 0